Unacylated tridecaptin A1 acts as an effective sensitiser of Gram-negative bacteria to other antibiotics

Stephen A. Cochrane, John C Vederas

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A derivative of the linear cationic lipopeptide tridecaptin A1 missing the N-terminal lipophilic acyl group, termed H-TriA1, is devoid of antimicrobial activity but is extremely effective at sensitising Gram-negative bacteria to certain antibiotics. H-TriA1 has low cytotoxicity compared with the natural peptide and in low concentrations it can substantially lower the minimum inhibitory concentration (MIC) of some antibiotics against strains of Escherichia coli, Campylobacter jejuni and Klebsiella pneumoniae. In particular, the MIC of rifampicin was lowered 256-512-fold against K. pneumoniae strains using low concentrations of H-TriA1. H-TriA1 does not exert its synergistic effect through partial membrane lysis, but does bind to model bacterial membranes in a manner akin to the natural peptide. Formation of this stable secondary structure on the outer membrane may account for the observed synergistic activity.
Original languageEnglish
Pages (from-to)493-499
JournalInternational Journal of Antimicrobial Agents
Volume44
Issue number6
Early online date27 Sep 2014
DOIs
Publication statusPublished - Dec 2014

Keywords

  • Antibiotic
  • Gram-negative bacteria
  • Lipopeptide
  • Rifampicin
  • Tridecaptin
  • Vancomycin

Fingerprint Dive into the research topics of 'Unacylated tridecaptin A1 acts as an effective sensitiser of Gram-negative bacteria to other antibiotics'. Together they form a unique fingerprint.

Cite this